TY - JOUR
TI - Surgical oncology during the post-COVID-19 era: What is next?
AU - Lianos, G.D.
AU - Frountzas, M.
AU - Schizas, D.
AU - Baltagiannis, E.G.
AU - Alexiou, G.A.
AU - Bali, C.
AU - Glantzounis, G.K.
AU - Mitsis, M.
AU - Vlachos, K.
JO - International Journal of Surgical Oncology
PY - 2023
VL - 127
TODO - 1
SP - 7-10
PB - John Wiley and Sons Inc
SN - 2090-1402, 2090-1410
TODO - 10.1002/jso.27104
TODO - cancer patient;  cancer recurrence;  cancer surgery;  cancer survival;  complication;  coronavirus disease 2019;  disease severity;  human;  pandemic;  recurrence risk;  Review;  surgical oncology;  tumor growth;  epidemiology;  neoplasm, COVID-19;  Humans;  Neoplasms;  Pandemics;  SARS-CoV-2;  Surgical Oncology
TODO - During first outburst of COVID-19, several strategies had been applied for surgical oncology patients to minimize COVID-19 transmission. COVID-19 infection seemed to compromise survival and major complication rates of surgical oncology patients. However, survival, tumor progression and recurrence rates of surgical oncology patients were associated to the consequences of COVID-19 pandemic on their management. In addition, the severity of COVID-19 infections has been downgraded. Therefore, management of surgical oncology patients should be reconsidered. © 2022 Wiley Periodicals LLC.
ER -